" /> Diaphyseal medullary stenosis with malignant fibrous histiocytoma - CISMeF





Preferred Label : Diaphyseal medullary stenosis with malignant fibrous histiocytoma;

Symbol : DMSMFH;

CISMeF acronym : BDMF; DMSMFH;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : BDMF; Bone dysplasia with medullary fibrosarcoma; Myopathy, limb-girdle, with bone fragility; Bone dysplasia with malignant fibrous histiocytoma;

Description : Diaphyseal medullary stenosis with malignant fibrous histiocytoma is an autosomal dominant bone dysplasia characterized by pathologic fractures due to abnormal cortical growth and diaphyseal medullary stenosis. The fractures heal poorly, and there is progressive bowing of the lower extremities. In 2 families, affected individuals also showed a limb-girdle myopathy, with muscle weakness and atrophy. Approximately 35% of affected individuals develop an aggressive form of bone sarcoma consistent with malignant fibrous histiocytoma or osteosarcoma. Thus, the disorder may be considered a tumor predisposition syndrome (summary by Camacho-Vanegas et al., 2012).;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the methylthioadenosine phosphorylase gene (MTAP, 156540.0001);

Neoplasia : Malignant fibrous histiocytoma (in about 35% of patients); Osteosarcoma; Fibrosarcoma;

Laboratory abnormalities : Serum alkaline phosphatase normal or mildly increased; Serum creatine kinase normal or mildly increased;

Prefixed ID : #112250;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.